Alexander P. Rozin

Alexander P. Rozin

Auto-generated profile, based on publicly available information

Alexander P. Rozin

B. Shine Department of Rheumatology, Rambam Health Care Campus and Technion, Haifa, Israel

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2005 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ARAlexander Rozin
Alexander Rozin
MYMordechai Yigla
Mordechai Yigla
LGLuda Guralnik
Luda Guralnik
ZKZohar Keidar
Zohar Keidar
EVEuvgeni Vlodavsky
Euvgeni Vlodavsky
ABAlexandra Balbir-Gurman
Alexandra Balbir-Gurman

1 January 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ARAlexander P Rozin
Alexander P Rozin
SAPHO syndrome, representing a constellation of synovitis, acne, palmo-plantar pustulosis, hyperostosis, and osteitis, is now recognized as a distinct medical entity: a reactive infectious osteitis. Genetic, immunological, and bacterial mechanisms are implicated in the development of the disease. Diagnostic problems may arise due to non-complete manifestations of SAPHO: either acne and arthritis or acne and anterior wall osteitis with an unclear pustulosis history. The interventional study of Assmann et al. is a significant addition to a long range of publications showing an association of SAPHO with Propionibacterium acnes. Randomized control studies are needed to confirm the effects of antibiotic therapy.

2 April 2006 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ARA. P. Rozin
A. P. Rozin
ANA. M. Nahir
A. M. Nahir

17 June 2009 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ARAlexander P. Rozin
Alexander P. Rozin
OKOlga Kagna
Olga Kagna
YSYizhak Shiller
Yizhak Shiller

1 July 2004 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
ARA P Rozin
A P Rozin
ABA Balbir-Gurman
A Balbir-Gurman
LGL Gilead
L Gilead
DSD Slodownik
D Slodownik
A marginal biopsy was performed, which highlighted a massive neutrophil infiltrate invading subcutaneous fat with necrotic debris associated with PG, with no evidence of vasculitis, malignancy, or infection. The patient had had seropositive rheumatoid arthritis for 32 years and her joint disease was controlled with long term treatment with azathioprine 150 mg/day. Despite the large rapidly progressive skin lesion and threat of leg amputation we decided to stop azathioprine and to begin combined therapy. This treatment included intravenous monthly cyclophosphamide pulse therapy 1000 mg (20 mg/kg), oral cyclosporin A 100 mg/day (2 mg/kg), a moderate dose of prednisone 30 mg/day (0.6 mg/kg) with tapering to 20 mg/day after 2 months, and a local treatment. To achieve a clean wound, she underwent one session of maggot debridement treatment (MDT). After confirming a normal ankle brachial index by duplex we started to apply two layer pressure dressings with occasional granulation tissue promoters. After 3 months of the treatment the wound healed completely (fig 1B). Three additional monthly pulses of cyclophosphamide were given. The patient’s present treatment comprises cyclosporin A 2 mg/kg and prednisone 10 mg/day. She is well, has normal daily living, and no active arthritis.

1 October 2009 in Clinical Immunology
Verified
Journal Article
Closed access
KZKeren Zohar
Keren Zohar
YBYolanda Braun-Moscovici
Yolanda Braun-Moscovici
DMDoron Markovits
Doron Markovits
ARAlexander Rozin
Alexander Rozin
MNMenahem Nahir
Menahem Nahir
DMDoron Melamed
Doron Melamed